Show Summary Details
Page of

Disease caused by environmental mycobacteria 

Disease caused by environmental mycobacteria

Disease caused by environmental mycobacteria

J. van Ingen

and P.D.O. Davies



Chapter heavily revised.

Updated on 31 May 2012. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 30 March 2017

Introduction—there are over 130 species of mycobacteria; species other than M. tuberculosis complex and M. leprae are collectively referred to as the nontuberculous or environmental mycobacteria. Nontuberculous mycobacteria (NTM) are divided into two groups, the slow growers and the rapid growers. The most common organisms causing human disease are the slow-growing species M. avium complex and M. kansasii and, less commonly, M. marinum, M. xenopi, M. simiae, M. malmoense, and M. ulcerans. The rapid growers that are human pathogens are M. abscessus, M. fortuitum, and M. chelonae.

Ecology and epidemiology—NTM are ubiquitous in the environment and have been isolated from water, soil, domestic and wild animals, milk, and food products. Transmission to humans is though inhalation, ingestion, or traumatic inoculation. The prevalence of NTM infections is likely to have been underestimated, and appears to be increasing in developed countries.

Clinical features—four clinical syndromes have been described: (1) pulmonary disease; (2) lymphadenitis; (3) postinoculation mycobacteriosis; (4) disseminated disease. Cervical lymphadenitis is the most common presentation in children whereas chronic pulmonary disease is more frequent in adults.

Diagnosis—microscopic examination using acid fast stains and culture on appropriate media remain the cornerstone of diagnosis. The use of techniques such high performance liquid chromatography (HPLC), polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis and 16S ribosomal DNA sequencing have enabled more accurate speciation of nontuberculous mycobacteria.

Treatment—this depends on the site and severity of the infection, the presence of predisposing conditions, and the species of mycobacterium. Therapy of disease due to slow growers is usually based on regimens containing clarithromycin or azithromycin; that for rapid growers is largely empirical. Antiretroviral therapy is more beneficial than antimycobacterial agents in patients with AIDS-related disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.